Reva Medical Files for IPO

8/16/10

San Diego-based Reva Medical, which is developing bioabsorbable stents for treating arterial disease, has filed for a $63 million IPO on the Australian Stock Exchange, according to PE Hub. Inteq Ltd., a boutique investment bank in Sydney, is serving as the lead underwriter. The company has raised about $57 million in venture capital funding from Domain Partners, Cereberus Capital Managemet, Brookside Capital, and Group Outcome, according to PE Hub.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @

By posting a comment, you agree to our terms and conditions.

  • http://www.johnconner.com john conner

    Has the FDA commented on the bioabsorbable stints which Reva is working on? Also, These stints have a huge upside, most bioabsorbable stints, I believe, are for “drug delivery?” only, not arterial disease. Good luck Reva!

  • Garry Peacock

    Any idea who will be handling the IPO in the USA? Also any indication when and how much each share will be?
    Will this be a patented item and has the FDA approved the product?